SCHOTT Pharma AG & Co. KGaA Balance Sheet

Financials in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Cash & Equivalents	23.18	23.18	24.36	28.8	27.86	18.61
Short-Term Investments	3.25	3.25	1.53	1.49	-	-
Cash & Short-Term Investments	26.43	26.43	25.89	30.28	27.86	18.61
Cash Growth	2.09%	2.09%	-14.51%	8.70%	49.73%	-
Accounts Receivable	235.62	235.62	223.7	199.05	150.94	130.76
Other Receivables	33.73	33.73	29.71	27.61	15.76	12.71
Receivables	411.45	411.45	289.69	389.23	187.13	153.52
Inventory	140.45	140.45	138.94	128.94	83.52	63.22
Prepaid Expenses	2.77	2.77	3.13	2.94	1.88	1.08
Other Current Assets	7.51	7.51	10.69	3.13	1.77	2.56
Total Current Assets	588.6	588.6	468.34	554.52	302.16	238.98
Property, Plant & Equipment	723.49	723.49	637.81	517.21	334.14	267
Long-Term Investments	85.06	85.06	79.07	79.83	62.26	49.46
Goodwill	29.35	29.35	29.49	30.95	29.33	28.39
Other Intangible Assets	1.12	1.12	1.45	1.92	1.72	2.61
Long-Term Deferred Tax Assets	14.33	14.33	14.83	11.75	10.11	9.48
Other Long-Term Assets	0.32	0.32	0.84	0.33	0.18	0.08
Total Assets	1,442	1,442	1,232	1,197	739.89	596.02
Accounts Payable	95.51	95.51	90.64	99.6	63.38	61.55
Accrued Expenses	42.43	42.43	52.86	46.58	39	30.95
Short-Term Debt	200.54	200.54	137.47	120.57	96.98	86.95
Current Portion of Leases	4.93	4.93	3.14	3.38	1.39	0.85
Current Income Taxes Payable	35.33	35.33	20.4	12.65	16.3	14.48
Current Unearned Revenue	24.3	24.3	20.5	14.76	8.84	0.82
Other Current Liabilities	32.45	32.45	26.14	25.49	18.32	14.26
Total Current Liabilities	435.48	435.48	351.15	323.02	244.21	209.86
Long-Term Leases	80.87	80.87	69.19	71.43	2.21	3.38
Long-Term Unearned Revenue	78.61	78.61	66.14	39.95	19.85	6.91
Long-Term Deferred Tax Liabilities	20.52	20.52	24.82	20.7	11.75	8.07
Other Long-Term Liabilities	7.32	7.32	9.57	17.73	8.3	7.98
Total Liabilities	650	650	539.65	487.46	320.48	280.36
Common Stock	150.62	150.62	150.62	-	-	-
Comprehensive Income & Other	639.79	639.79	539.82	707.28	417.96	314.52
Total Common Equity	790.41	790.41	690.43	707.28	417.96	314.52
Minority Interest	1.86	1.86	1.75	1.77	1.46	1.14
Shareholders' Equity	792.27	792.27	692.18	709.04	419.42	315.66
Total Liabilities & Equity	1,442	1,442	1,232	1,197	739.89	596.02
Total Debt	286.34	286.34	209.81	195.38	100.58	91.18
Net Cash (Debt)	-259.91	-259.91	-183.92	-165.09	-72.72	-72.58
Net Cash Per Share	-1.73	-1.73	-1.22	-1.10	-0.48	-0.48
Filing Date Shares Outstanding	150.61	150.61	150.61	150.61	150.61	150.61
Total Common Shares Outstanding	150.61	150.61	150.61	150.61	150.61	150.61
Working Capital	153.12	153.12	117.19	231.5	57.95	29.12
Book Value Per Share	5.25	5.25	4.58	4.70	2.78	2.09
Tangible Book Value	759.94	759.94	659.49	674.41	386.91	283.52
Tangible Book Value Per Share	5.05	5.05	4.38	4.48	2.57	1.88
Land	336.47	336.47	260.95	240.49	143.56	133.19
Machinery	730.55	730.55	615.67	565.37	443.39	397.85
Construction In Progress	192.49	192.49	250.62	173.47	122.12	86.35

Source: S&P Capital IQ. Standard template. Financial Sources.